Similar articles

• Antibody to human T-cell lymphotropic virus type I in Australian aborigines.

  May JT, Stent G, Schnagl RD. May JT, et al. Med J Aust. 1988 Jul 18;149(2):104. doi: 10.5694/j.1326-5377.1988.tb120516.x. Med J Aust. 1988. PMID: 2839756 No abstract available.
• Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan.

  Wang CH, Chen CJ, Hu CY, You SL, Chu CT, Chou MJ, Essex M, Blattner WA, Liu CH, Yang CS. Wang CH, et al. Cancer Res. 1988 Sep 1;48(17):5042-4. Cancer Res. 1988. PMID: 2900678
• Seroprevalence of human T-cell lymphotropic virus type 1 among homosexual men in the United States.

  Manns A, Obrams I, Detels R, Diwan A, Ginzburg HM, Goedert JJ, Blattner WA. Manns A, et al. N Engl J Med. 1988 Aug 25;319(8):516-7. doi: 10.1056/NEJM198808253190811. N Engl J Med. 1988. PMID: 2900465 No abstract available.
• Lack of seroconversion to human T-cell lymphotropic virus, type III, after intravenous immune globulin.

  Bussel JB. Bussel JB. Transfusion. 1986 Jul-Aug;26(4):399. doi: 10.1046/j.1537-2995.1986.26486262755.x. Transfusion. 1986. PMID: 3014693 No abstract available.
• Human T-lymphotropic retroviruses in adult T-cell leukemia-lymphoma and acquired immune deficiency syndrome.

  Sarin PS, Gallo RC. Sarin PS, et al. J Clin Immunol. 1984 Nov;4(6):415-23. doi: 10.1007/BF00916570. J Clin Immunol. 1984. PMID: 6096392 Review. No abstract available.